These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 33889518)
1. Prognostic value of baseline and change in neutrophil-to-lymphocyte ratio for survival in advanced non-small cell lung cancer patients with poor performance status receiving PD-1 inhibitors. Chen S; Li R; Zhang Z; Huang Z; Cui P; Jia W; Zhang S; Tao H; Wang L; Li X; Wang J; Ma J; Liu Z; Huang D; Zheng X; Saito Y; Ichiki Y; Hu Y Transl Lung Cancer Res; 2021 Mar; 10(3):1397-1407. PubMed ID: 33889518 [TBL] [Abstract][Full Text] [Related]
2. Risk Stratification According to Baseline and Early Change in Neutrophil-to-Lymphocyte Ratio in Advanced Non-Small Cell Lung Cancer Treated with Chemoimmunotherapy: A Multicenter Real-World Study. Matsumoto K; Yamamoto Y; Shiroyama T; Kuge T; Mori M; Tamiya M; Kinehara Y; Tamiya A; Suzuki H; Tobita S; Ueno K; Niki T; Nagatomo I; Takeda Y; Kumanogoh A Target Oncol; 2024 Sep; 19(5):757-767. PubMed ID: 38990462 [TBL] [Abstract][Full Text] [Related]
3. The postoperative neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after the complete resection of stage I non-small cell lung cancer. Jin F; Han A; Shi F; Kong L; Yu J Onco Targets Ther; 2016; 9():6529-6537. PubMed ID: 27799800 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of neutrophil-to-lymphocyte ratio change in patients with locally advanced non-small cell lung cancer treated with thoracic radiotherapy. Yin X; Chen H; Sun Y; Xiao L; Lu H; Guo W; Yang H; Zhou J; Fan K; Liang W Sci Rep; 2024 May; 14(1):11984. PubMed ID: 38796631 [TBL] [Abstract][Full Text] [Related]
5. Significance of baseline and change in neutrophil-to-lymphocyte ratio in predicting prognosis: a retrospective analysis in advanced pancreatic ductal adenocarcinoma. Chen Y; Yan H; Wang Y; Shi Y; Dai G Sci Rep; 2017 Apr; 7(1):753. PubMed ID: 28392554 [TBL] [Abstract][Full Text] [Related]
6. Postoperative Elevations of Neutrophil-to-lymphocyte and Platelet-to-lymphocyte Ratios Predict Postoperative Pulmonary Complications in Non-small Cell Lung Cancer Patients: A Retrospective Cohort Study. Wang Y; Hu X; Su MC; Wang YW; Che GW Curr Med Sci; 2020 Apr; 40(2):339-347. PubMed ID: 32337695 [TBL] [Abstract][Full Text] [Related]
7. Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer. Bagley SJ; Kothari S; Aggarwal C; Bauml JM; Alley EW; Evans TL; Kosteva JA; Ciunci CA; Gabriel PE; Thompson JC; Stonehouse-Lee S; Sherry VE; Gilbert E; Eaby-Sandy B; Mutale F; DiLullo G; Cohen RB; Vachani A; Langer CJ Lung Cancer; 2017 Apr; 106():1-7. PubMed ID: 28285682 [TBL] [Abstract][Full Text] [Related]
8. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab. Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096 [TBL] [Abstract][Full Text] [Related]
9. Baseline neutrophil-to- ratio combined with the change during treatment provides risk stratification for metastatic malignant melanoma patients treated with PD-1 inhibitors in a Chinese population. Wang C; Liu S; Li X; Cui K; Zhang W; Du Y Front Oncol; 2023; 13():1118301. PubMed ID: 37152022 [TBL] [Abstract][Full Text] [Related]
10. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics. Wang J; Liu Y; Mi X; Shao M; Liu L Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020 [TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of long-term survival factors in patients with advanced non-small cell lung cancer treated with nivolumab. Murakami Y; Tamiya A; Taniguchi Y; Adachi Y; Enomoto T; Azuma K; Inagaki Y; Kouno S; Matsuda Y; Okishio K; Atagi S Thorac Cancer; 2022 Feb; 13(4):593-601. PubMed ID: 34989133 [TBL] [Abstract][Full Text] [Related]
12. Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) May Predict the Outcomes of Advanced Non-small-cell Lung Cancer (NSCLC) Patients Treated With Immune Checkpoint Inhibitors (ICIs). Li Y; Zhang Z; Hu Y; Yan X; Song Q; Wang G; Chen R; Jiao S; Wang J Front Oncol; 2020; 10():654. PubMed ID: 32656072 [No Abstract] [Full Text] [Related]
13. The prognostic value of neutrophil-lymphocyte ratio is superior to derived neutrophil-lymphocyte ratio in advanced gastric cancer treated with preoperative chemotherapy and sequential R0 resection: a 5-year follow-up. Jin H; Sun J; Zhu K; Liu X; Zhang Q; Shen Q; Gao Y; Yu J Onco Targets Ther; 2017; 10():2655-2664. PubMed ID: 28579803 [TBL] [Abstract][Full Text] [Related]
14. Dynamic evaluation of neutrophil-to-lymphocyte ratio as prognostic factor in stage III non-small cell lung cancer treated with chemoradiotherapy. Palomar-Abril V; Soria-Comes T; Campos ST; Ureste MM; Bosch VG; Maiques ICM Clin Transl Oncol; 2020 Dec; 22(12):2333-2340. PubMed ID: 32449125 [TBL] [Abstract][Full Text] [Related]
15. Clinical value of neutrophil-to-lymphocyte ratio in patients with non-small-cell lung cancer treated with PD-1/PD-L1 inhibitors. Jiang T; Bai Y; Zhou F; Li W; Gao G; Su C; Ren S; Chen X; Zhou C Lung Cancer; 2019 Apr; 130():76-83. PubMed ID: 30885355 [TBL] [Abstract][Full Text] [Related]
16. Prognostic utility of inflammation-based biomarkers, neutrophil-lymphocyte ratio and change in neutrophil-lymphocyte ratio, in surgically resected lung cancers. Thompson D; Perry LA; Renouf J; Vodanovich D; Hong Lee AH; Dimiri J; Wright G Ann Thorac Med; 2021; 16(2):148-155. PubMed ID: 34012481 [TBL] [Abstract][Full Text] [Related]
17. Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer. Derman BA; Macklis JN; Azeem MS; Sayidine S; Basu S; Batus M; Esmail F; Borgia JA; Bonomi P; Fidler MJ BMC Cancer; 2017 Feb; 17(1):141. PubMed ID: 28209123 [TBL] [Abstract][Full Text] [Related]
18. Increasing neutrophil-to-lymphocyte ratio following radiation is a poor prognostic factor and directly correlates with splenic radiation dose in pancreatic cancer. Wolfe AR; Siedow M; Nalin A; DiCostanzo D; Miller ED; Diaz DA; Arnett A; Cloyd JM; Dillhoff M; Ejaz A; Tsung A; Williams TM Radiother Oncol; 2021 May; 158():207-214. PubMed ID: 33667588 [TBL] [Abstract][Full Text] [Related]
19. The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer. Banna GL; Cortellini A; Cortinovis DL; Tiseo M; Aerts JGJV; Barbieri F; Giusti R; Bria E; Grossi F; Pizzutilo P; Berardi R; Morabito A; Genova C; Mazzoni F; Di Noia V; Signorelli D; Gelibter A; Macerelli M; Rastelli F; Chiari R; Rocco D; Gori S; De Tursi M; Di Marino P; Mansueto G; Zoratto F; Filetti M; Montrone M; Citarella F; Marco R; Cantini L; Nigro O; D'Argento E; Buti S; Minuti G; Landi L; Guaitoli G; Lo Russo G; De Toma A; Donisi C; Friedlaender A; De Giglio A; Metro G; Porzio G; Ficorella C; Addeo A ESMO Open; 2021 Apr; 6(2):100078. PubMed ID: 33735802 [TBL] [Abstract][Full Text] [Related]
20. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]